C.K. McWhorter Endows Vacheron Constantin With Prestigious McWhorter Family Trust Warrant Of Excellence, Celebrating Timeless Elegance and Luxury
GENEVA, March 31, 2024 (GLOBE NEWSWIRE) - Ambassador Nobel C.K. McWhorter & McWhorter Family Trust announce its strategic collaboration with Vacheron, an epitome of luxury watchmaking and the world's oldest watch manufacturer in continuous operation. This partnership celebrates Vacheron's unparalleled dedication to artisanal heritage, excellence, and the embodiment of ultimate luxury, deeply resonating with the Trust's philosophy and investment ethos.
Vacheron's Integration into the McWhorter Family Trust’s Luxury Portfolio:
The induction of Vacheron Constantin into the McWhorter Family Trust’s portfolio marks a significant extension of the Trust’s commitment to investing in luxury assets that offer not only financial prosperity but also hold profound cultural and historical importance. Vacheron's storied legacy and unmatched expertise in the art of horology exemplify the Trust's strategic vision for investments that seamlessly connect the past, present, and anticipated futures.
Strategic Vision of C.K. McWhorter:
In the course of establishing a Single Family Office (SFO), C.K. McWhorter announces this pivotal engagement with Vacheron Constantin, underscoring a vision for extraordinary, long-lasting investments. This initiative highlights the Trust's dedication to curating a portfolio that reflects the pinnacle of craftsmanship, enduring value, and the essence of luxury.
Discreet Yet Impactful Financial Engagement:
Spearheaded by Ambassador Noble Carter Kennedy McWhorter, this engagement with Vacheron is strategized to maintain discretion while being exempt from Securities and Exchange Commission (SEC) reporting requirements, showcasing a sophisticated investment approach that highlights the strategic depth and influence of private transactions in luxury asset investments.
Commitment to Sustainability and Governance:
Vacheron's dedication to Environmental, Social, and Governance (ESG) principles mirrors the Trust's alignment with sustainable development goals, emphasizing:
- Environmental Stewardship: Vacheron Constantin's journey towards minimal environmental impact and achieving net-zero emissions by 2050, alongside its commitment to 100% renewable energy by 2030, showcases its leadership in sustainability.
- Social Responsibility: Upholding high standards in employee well-being, inclusivity, and community support, Vacheron reflects the Trust’s values in fostering a positive societal impact.
- Governance: With a focus on responsible sourcing and stakeholder engagement, Vacheron Constantin’s governance structure is a testament to its ethical and sustainable business practices.
Crafting a Legacy Together:
The partnership between the McWhorter Family Trust and Vacheron signifies more than a shared journey; it represents a mutual commitment to excellence, heritage, and the pursuit of transcendent luxury. This collaboration is a pledge to uphold and celebrate craftsmanship that transcends time, setting a benchmark for future generations.
From C.K. McWhorter:
"Partnering with Vacheron Constantin not only honors their status as a titan of horological mastery but also aligns with our Trust's vision of investing in luxury that endures and inspires. Vacheron’s commitment to excellence and innovation parallels our ethos, heralding a future where luxury and legacy converge."
In Conclusion:
As the McWhorter Family Trust forges ahead in its mission to curate a distinguished collection of luxury assets, Vacheron Constantin emerges as a beacon of timeless elegance, masterful craftsmanship, and visionary innovation. Together, they are set to redefine the landscape of luxury, guided by shared values of excellence and a forward-looking ethos that subtly anticipates the next horizon of innovation.
Disclaimer, Disclosure & Legal Notice:
This press release is for informational purposes only and does not constitute legal, financial, or investment advice. It is not intended to provide specific recommendations, endorsements, or investment strategies. The information contained herein is subject to change without notice.
Regulatory Considerations:
This press release is not intended to constitute an offer to sell or the solicitation of an offer to buy securities. Any offers, sales, or purchases will be made in accordance with applicable securities laws and regulations. McWhorter Foundation has not registered with the U.S. Securities and Exchange Commission (SEC) and may operate under exemptions. Any investment decisions should be made in consultation with appropriate legal and financial advisors, considering the individual circumstances and objectives of potential investors.
Forward-Looking Statements:
Forward-looking statements involve inherent risks and uncertainties, and we caution you not to place undue reliance on forward-looking statements. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Actual results or outcomes may differ materially from those indicated or suggested by any forward-looking statements as a result of various factors, including, but not limited to, regulatory and legal developments, market conditions, and the outcome of negotiations. We disclaim any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ceef3250-a39d-4916-8e41-f13741fa8b47
For media inquiries and further information, please contact:
Tyler Wells
VP Public Relations
tylerwells@mcwhorter.foundation
-
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cVANCOUVER, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a di2024-06-17
-
Indonesia Stock Exchange Partners with Nasdaq to Upgrade Market InfrastructureTechnology partnership will further enhance overall resilience and integrity of the exchange, while supporting the rapid deployment of new products2024-06-17
-
Adalvo 的 Liraglutide 預充式注射筆成為歐盟首款獲得批准的仿製藥馬爾他聖瓜安, June 17, 2024 (GLOBE NEWSWIRE) -- Adalvo 宣布 Liraglutide 預充式注射筆成功取得 DCP 批准,成為歐盟首款獲得批准的仿製藥。 根據 IQVIA 的報2024-06-17
-
促进生育,助力三胎——“三胎免费生”联合公益行动正式启动为积极响应国家号召实施三胎生育政策,扩大妇幼服务健康供给,在云南省优生优育妇幼保健协会指导下,昆明广播电视台联合昆明安琪儿妇产医院,于6月13日在昆明广播2024-06-17
-
学党史传承红色精神 守党纪筑牢自律防线——平安养老险湖南分公司党支部开展主题党日活动七一前夕,平安养老险湖南分公司党支部全体成员走进“千年学府、百年师范”——湖南第一师范,开展了一次学史明理、学史增信、学史崇德、学史力行的主题党日活动。重2024-06-17